ArticleBMJ paediatrics open2026
Association of red blood cell transfusions with bronchopulmonary dysplasia in preterm infants: a retrospective cohort study.
Article in BMJ paediatrics open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBronchopulmonary dysplasia (BPD) is the most common pulmonary complication in preterm neonates. Emerging evidence links red blood cell (RBC) transfusions to increased BPD risk.
methodsWe conducted a retrospective cohort study of all infants of extremely low birth weight (ELBW) admitted to our NICU from January 2021 to December 2023. Infants enrolled within 7 days of birth were followed until 36 weeks' postmenstrual age (PMA) or until discharge or death-whichever came first. We extracted data on RBC transfusions, baseline characteristics and BPD diagnosis from validated electronic health records. To minimise confounding, we applied propensity score matching (PSM), overlap weighting (OW), multivariable logistic regression (adjusted for prespecified covariates), and restricted cubic spline (RCS) regression to assess nonlinear dose-response relationships.
resultsAmong 746 very low birth weight (VLBW) infants, BPD incidence was 35.2% (263/746). Before PSM, BPD occurred in 48.3% (224/464) of transfused infants vs 13.8% (39/282) of non-transfused infants (unadjusted OR=5.81; 95% CI: 3.96 to 8.53; p<0.001). After PSM (173 matched pairs), BPD remained significantly higher in the transfused group (39.3% vs 19.6%; adjusted OR=2.97; 95% CI: 1.76 to 5.04; p<0.001). OW yielded consistent results (OR=2.53; 95% CI: 1.64 to 3.91; p<0.001). In transfused infants (n=464), RCS regression showed a nonlinear association between timing of first transfusion and BPD risk (p=0.03). Neither total transfusion count nor blood storage duration correlated with BPD.
conclusionsRBC transfusions are linked to a greater risk of BPD in preterm infants, with the timing of the initial transfusion having a nonlinear effect on the development of BPD. These findings highlight the need for further investigation into optimal transfusion strategies to mitigate BPD risk in this vulnerable population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.